These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 6678159

  • 1. Combined effects of cholestyramine and probucol on regression of atherosclerosis in rhesus monkey aortas.
    Wissler RW, Vesselinovitch D.
    Appl Pathol; 1983; 1(2):89-96. PubMed ID: 6678159
    [Abstract] [Full Text] [Related]

  • 2. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D, Bonfiglioli D, Tirrito M, Pogliaghi I, Branchi A, Cabrini E.
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
    [Abstract] [Full Text] [Related]

  • 3. Combined treatment of probucol with diltiazem regresses atherosclerosis induced by 196 cholesterol diet in rabbit aorta.
    Kouzuma R, Tasaki H, Komura T, Nakashima Y, Kuroiwa A, Tanimoto A, Koide O.
    Artery; 1995 Sep; 21(6):337-51. PubMed ID: 8833232
    [Abstract] [Full Text] [Related]

  • 4. Promotive effect of elastase on regression of aortic atherosclerosis in cholesterol-fed quails.
    Toda T, Hokama S, Nagamine M, Takei H.
    Exp Pathol; 1989 Sep; 36(4):201-9. PubMed ID: 2767211
    [Abstract] [Full Text] [Related]

  • 5. Effect of indomethacin on serum lipids, lipoproteins, prostaglandins and the extent and severity of atherosclerosis in rhesus monkeys.
    Dhawan V, Ganguly NK, Majumdar S, Chakravarti RN.
    Can J Cardiol; 1992 Apr; 8(3):306-12. PubMed ID: 1576566
    [Abstract] [Full Text] [Related]

  • 6. Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primates.
    Kitamoto S, Nakano K, Hirouchi Y, Kohjimoto Y, Kitajima S, Usui M, Inoue S, Egashira K.
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1522-8. PubMed ID: 15178560
    [Abstract] [Full Text] [Related]

  • 7. Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status report.
    Walldius G, Carlson LA, Erikson U, Olsson AG, Johansson J, Mölgaard J, Nilsson S, Stenport G, Kaijser L, Lassvik C.
    Am J Cardiol; 1988 Jul 25; 62(3):37B-43B. PubMed ID: 3293415
    [Abstract] [Full Text] [Related]

  • 8. Effects of captopril on atherosclerosis in cynomolgus monkeys.
    Aberg G, Ferrer P.
    J Cardiovasc Pharmacol; 1990 Jul 25; 15 Suppl 5():S65-72. PubMed ID: 1694934
    [Abstract] [Full Text] [Related]

  • 9. The effect of probucol and cholestyramine combination therapy in severe familial hypercholesterolaemia.
    Jackson JM, Lee HA.
    Atherosclerosis; 1984 Jul 25; 51(2-3):189-97. PubMed ID: 6743378
    [Abstract] [Full Text] [Related]

  • 10. Evidence for regression of advanced atherosclerotic plaques.
    Wissler RW.
    Artery; 1979 May 25; 5(5):398-408. PubMed ID: 262163
    [Abstract] [Full Text] [Related]

  • 11. Aneurysm formation in experimental atherosclerosis: relationship to plaque evolution.
    Zarins CK, Glagov S, Vesselinovitch D, Wissler RW.
    J Vasc Surg; 1990 Sep 25; 12(3):246-56. PubMed ID: 2398583
    [Abstract] [Full Text] [Related]

  • 12. A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia.
    Jones DB, Simpson HC, Slaughter P, Lousley S, Carter RD, Cobbe SM, Mann JI.
    Atherosclerosis; 1984 Oct 25; 53(1):1-7. PubMed ID: 6388586
    [Abstract] [Full Text] [Related]

  • 13. Aortic lysosomal hydrolases and pathological alterations in hypertensive and/or atherogenic diet fed rhesus monkeys.
    Dhaunsi GS, Majumdar S, Chakravarti RN.
    J Exp Pathol; 1992 Oct 25; 6(1-2):1-9. PubMed ID: 1625032
    [Abstract] [Full Text] [Related]

  • 14. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
    Miyazaki M, Hosoki K, Okunishi H, Ishii K, Ikeno A, Okazaki Y.
    Arzneimittelforschung; 1994 Mar 25; 44(3):288-97. PubMed ID: 8192692
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of individualized long-term therapy with niacin and probucol in reduction of serum cholesterol.
    Cohen L, Morgan J.
    J Fam Pract; 1988 Feb 25; 26(2):145-50. PubMed ID: 3339318
    [Abstract] [Full Text] [Related]

  • 16. Atherosclerosis in the tongue of the rhesus monkey.
    Mostofi RS, Goepp RA.
    J Dent Res; 1981 Nov 25; 60(11):1876-85. PubMed ID: 6945326
    [Abstract] [Full Text] [Related]

  • 17. Diet-induced atherosclerosis in cynomolgus monkey aorta and regression by the sixth-month observation.
    Yamada T, Yoshikuni Y, Taira M, Yoshida-Suzuka H, Kimura K, Sakurai I, Takenaka O.
    Angiology; 1992 Dec 25; 43(12):1008-19. PubMed ID: 1466482
    [Abstract] [Full Text] [Related]

  • 18. Effects of probucol on xanthomata regression in familial hypercholesterolemia.
    Yamamoto A, Matsuzawa Y, Yokoyama S, Funahashi T, Yamamura T, Kishino B.
    Am J Cardiol; 1986 Jun 27; 57(16):29H-35H. PubMed ID: 3728307
    [Abstract] [Full Text] [Related]

  • 19. Use of diet and probucol.
    Rapado A, Castrillo JM, Díaz-Curiel M.
    Arch Intern Med; 1979 Sep 27; 139(9):1062-3. PubMed ID: 475528
    [No Abstract] [Full Text] [Related]

  • 20. The effect of various dietary regimens and cholestyramine on aortic glycosaminoglycans during regression of atherosclerotic lesions in rhesus monkeys.
    Radhakrishnamurthy B, Ruiz HA, Dalferes ER, Vesselinovitch D, Wissler RW, Berenson GS.
    Atherosclerosis; 1979 May 27; 33(1):17-28. PubMed ID: 111684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.